Bullseye Asset Management LLC Catalent, Inc. Transaction History

Bullseye Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $1.59 Million - $1.96 Million	-15,636 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $11,250 - $13,802	-131 Reduced 0.83%	15,636 $1.63 Million
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $654 - $832	-9 Reduced 0.06%	15,767 $1.35 Million
Q2 2020 Aug 11, 2020	BUY	$48.02 - $79.04 $757,563 - $1.25 Million	15,776 New	15,776 $1.16 Million

484

172M

865K

687K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.2B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bullseye Asset Management LLC with notifications on news.